Chromobacterium violaceum is an opportunistic pathogen in humans. Nearly 150 cases have been reported worldwide. The usual presentation is with an initial localized skin lesion and progression to multiple liver and lung abscesses and finally fatal septicemia. Progression is usually seen in immunocompromised individuals or when appropriate antimicrobial therapy was delayed. Mortality ranges up to 60% if not promptly treated. A 73-year-old male presented with febrile urinary tract infection (UTI). His urine culture grew C. violaceum. Neither was he immunocompromised nor was he having any risk factor for this infection. He was not admitted in any hospital in the recent past. He did not have any urological intervention in the past. He was treated successfully with culture sensitive antibiotics. He responded well and he continues to be asymptomatic at 6 months of follow-up. The incidence of UTI by C. violaceum is on the rise. Only three cases of UTI caused by C. violaceum have been reported so far worldwide. This is the second case of symptomatic UTI caused by C. violaceum from the Indian subcontinent. The early recognition of this infection and prompt treatment with appropriate antibiotic go a long way in the prevention of sepsis and its associated morbidity.
Introduction
Chromobacterium violaceum, formerly known as bacillus violaceum manilae, was first described by Bergonzini in 1881. The true pathogenic nature of this organism was first found from a fatal infection in a buffalo from Philippines in 1905 by Woolley. [1] The very first human case was described by J E Lessler in Malaysia in 1927. [2] Around 150 human infections have been reported worldwide, mainly in Asia, the United States, Australia, and Africa. Nearly ten cases have been reported so far from India, mainly from the Southern and Eastern parts. Only three cases of isolated urinary tract infection (UTI) caused by C. violaceum have been reported so far.
Case Report
A 73-year-old male presented with the complaints of fever with chills for 2 days. He had increased frequency and his urine flow was slightly poor. He did not have any urgency or hematuria. He did not have any previous similar complaint. He was not a diabetic or hypertensive. He was not a smoker or chronic alcoholic. He had not undergone any hospital admission in the recent past. examination revealed Grade 1 benign enlargement of the prostate.
On evaluation, his total white blood cell count was 14,200 with neutrophilic predominance of 88%. The hemoglobin and platelet counts were normal. Erythrocyte sedimentation rate was 35 mm/h. His serum creatinine was 0.7 mg/dl. Urine microscopy revealed 10-12 pus cells, 2-3 red blood cell per high power field and bacteriuria. Ultrasound of the abdomen revealed prostatic enlargement of 55 cc and postvoid residue of 150 cc. There was no hydronephrosis and the renal parenchyma was normal.
Midstream clean-catch specimen of urine was plated for culture on MacConkey agar. After overnight aerobic incubation at 37°C, single type of colonies of 2-3 mm in diameter producing violet nondiffusible pigment was identified [ Figure 1 ]. These organisms were Gram-negative, motile bacilli, catalase and oxidase positive, indole negative, nonlactose fermenter on triple sugar iron media, utilized citrate, reduced nitrate, fermented mannitol, decarboxylated arginine, and fermented glucose with production of acid without any gas. Due to these biochemical characteristics and the specific violet pigment, the organism was identified as C. violaceum. Antibiogram was done by Kirby Bauer's disk diffusion susceptibility testing technique. The colony count was 10 4 and was sensitive to aminoglycosides, quinolones, carbapenems, cefoperazone, and piperacillin-tazobactam.
Blood culture was done after isolation of chromobacterium due to its propensity for dissemination, but it did not reveal any growth. Viral serologies were negative.
He was treated as an outpatient with levofloxacin 500 mg once a day for 10 days and was also started on alpha blocker for the prostate. His fever settled and his urinary symptoms got better. Febrile infection could have been due to cystitis. His follow-up urine culture after 2 weeks was sterile. The postvoid residual urine decreased to 30 cc. As for the prostatomegaly, he was advised combination therapy with alpha blocker plus 5-alpha-reductase inhibitor and he continues to be asymptomatic at 6 months of follow-up.
Discussion
C. violaceum is seen in tropical and subtropical regions as a saprophyte in soil and water. C. violaceum is a facultative anaerobic, motile, Gram-negative bacillus having a single polar flagellum and usually, one or two lateral flagella. The organism produces an antioxidant violet nondiffusible pigment called violacein which accounts for the specific color. Nine percent of the isolates are seen to be nonpigment producing and it can be extremely difficult to identify such cases. The pathogenicity does not depend on pigment production. [3] The organism rarely causes infection in humans, usually in the form of severe systemic infection with 60% mortality. The more common routes of entry are by entering the bloodstream through an open wound or oral route through contaminated food or water. Unusual routes of exposure include scuba diving or near drowning, playing in muddy water, and following surgical procedures such as appendicectomy and breast surgery.
Worldwide, only two cases of symptomatic UTI caused by C. violaceum have been reported so far. [4, 5] One case was from Orissa in India [4] and the other one from Nepal. [5] The case from Nepal was in an elderly immunocompromised male with chronic kidney disease and prior history of urinary tract instrumentation 4 weeks ago. The infection was probably contracted from the earlier urological intervention. The case from India was in a young immunocompetent male. Both the cases responded well to treatment and did not have any complication.
One case of asymptomatic bacteriuria has also been reported in a young immunocompetent male from Nepal. [6] He was treated with appropriate antibiotics due to the isolation of chromobacterium.
The described patient did not have any comorbidity. Neither the patient had any open wound in the recent past nor did he go for swimming. He did not have any urological intervention. The described case of UTI comes from the community setting probably due to unnoticed minor trauma. Being an immunocompetent individual without any comorbidity, the organism could have involved the urinary tract alone due to the prostatic enlargement and high residual urine volume. He did not have any complication due to prompt initiation of appropriate culture sensitive antibiotics.
This case is presented to highlight the following facts: 1. C. violaceum causing UTI as a community-acquired infection is on the rise 2. High degree of suspicion during culture reading is necessary and should not be ignored as a commensal or contaminant 3. Even in the absence of immunocompromised status and risk factors, C. violaceum can cause UTI 4. Early diagnosis and prompt treatment based on the culture and sensitivity help in complete resolution without any complication.
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